# GLYTR THERAPEUTICS, INC.: Maximizing GlyTR pan-cancer immunotherapy by enhancing target density

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | GLYTR THERAPEUTICS, INC. |
| Location | San Carlos, CA |
| Project | Maximizing GlyTR pan-cancer immunotherapy by enhancing target density |
| Project number | 4R42CA302415-02 |
| Mechanism | R42 |
| Institute | National Cancer Institute |
| Award | $1,002,331 |
| Awarded | 2026-09-16 |
| Project period | 2025-09-10 to 2028-08-31 |
| UEI | ZKQLT6S8LXY9 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11457445). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.